Stockscreener 앱 받기
12.10
6.98%
0.79
시간 외 거래:
11.99
-0.11
-0.91%
전일 마감가:
$11.31
열려 있는:
$10.78
하루 거래량:
40,779
Relative Volume:
0.75
시가총액:
$48.93M
수익:
$147.75M
순이익/손실:
$-284.23M
주가수익비율:
-4.1297
EPS:
-2.93
순현금흐름:
$-317.54M
1주 성능:
+2.28%
1개월 성능:
+75.11%
6개월 성능:
+22.84%
1년 성능:
+13.83%
1일 변동 폭
$10.65
$12.18
1주일 범위
$10.65
$12.60
52주 변동 폭
$4.50
$21.94
Fibrogen Inc Stock (FGEN) Company Profile
명칭
Fibrogen Inc
전화
415-978-1200
주소
350 BAY STREET, SAN FRANCISCO, CA
FGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FGEN
Fibrogen Inc
|
12.10 | 45.74M | 147.75M | -284.23M | -317.54M | -2.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-06-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-26 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-06-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-06-26 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-06-02 | 업그레이드 | Stifel | Hold → Buy |
| 2023-01-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-01-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-09-22 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-08-20 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-07-16 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-07-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-04-07 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-04-07 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2021-03-31 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-02-01 | 개시 | H.C. Wainwright | Buy |
| 2020-10-26 | 개시 | Raymond James | Underperform |
| 2020-07-10 | 재개 | Stifel | Buy |
| 2020-05-01 | 개시 | Cowen | Market Perform |
| 2020-04-27 | 개시 | BofA/Merrill | Neutral |
| 2019-05-29 | 재개 | Goldman | Neutral |
| 2019-05-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-04-12 | 개시 | Piper Jaffray | Neutral |
| 2019-02-11 | 재개 | Stifel | Buy |
| 2018-12-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2017-08-08 | 재확인 | Leerink Partners | Outperform |
| 2017-08-08 | 재확인 | Stifel | Buy |
| 2017-07-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-07-11 | 개시 | Jefferies | Buy |
| 2016-02-11 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2016-01-21 | 개시 | Credit Suisse | Neutral |
| 2015-12-04 | 개시 | Citigroup | Buy |
| 2015-09-23 | 개시 | Lake Street | Hold |
| 2015-07-29 | 개시 | Citigroup | Buy |
| 2015-07-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2014-12-09 | 개시 | Stifel | Buy |
모두보기
Fibrogen Inc 주식(FGEN)의 최신 뉴스
Smart tools for monitoring FibroGen Inc.’s price action2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Is FibroGen Inc. exposed to currency risksChart Signals & Consistent Return Investment Signals - خودرو بانک
Is FibroGen Inc. affected by consumer sentimentMarket Growth Report & Short-Term High Return Strategies - خودرو بانک
Using Python tools to backtest FibroGen Inc. strategiesJuly 2025 Rallies & Real-Time Market Trend Scan - Newser
FibroGen completes $220 million sale of Hong Kong subsidiary to AstraZeneca By Investing.com - Investing.com South Africa
FibroGen completes $220 million sale of Hong Kong subsidiary to AstraZeneca - Investing.com India
Using data filters to optimize entry into FibroGen Inc.July 2025 Sector Moves & Daily Volume Surge Signals - Newser
What is FibroGen Inc. s 5 year growth outlookJobs Report & Risk Managed Investment Signals - خودرو بانک
What’s the analyst consensus on FibroGen Inc.Weekly Loss Report & Weekly High Momentum Picks - خودرو بانک
FibroGen Inc. stock outlook for YEARWeekly Profit Analysis & AI Forecasted Stock Moves - Newser
How sentiment analysis helps forecast FibroGen Inc.Bond Market & Community Shared Stock Ideas - Newser
Regression analysis insights on FibroGen Inc. performance2025 Top Decliners & Step-by-Step Swing Trade Plans - Newser
How hedge fund analytics apply to FibroGen Inc. stockJuly 2025 Analyst Calls & Community Trade Idea Sharing Platform - Newser
Idiopathic Pulmonary Fibrosis Diagnostic and Treatment - GlobeNewswire
Idiopathic Pulmonary Fibrosis Diagnostic and Treatment Market Forecasts Report 2025-2030 | Boehringer Ingelheim and FibroGen Lead by Driving Innovations in Pharmacological and Diagnostic Advancements - Yahoo Finance
How does FibroGen Inc. score in quality rankings2025 Technical Patterns & Weekly Stock Performance Updates - خودرو بانک
Using fundamentals and technicals on FibroGen Inc.Portfolio Value Report & Low Risk High Win Rate Stock Picks - Newser
Is a relief rally coming for FibroGen Inc. holdersMarket Growth Report & Long-Term Capital Growth Ideas - Newser
How to build a dashboard for FibroGen Inc. stockMarket Movers & Low Drawdown Momentum Ideas - Newser
FibroGen Sells Subsidiary to AstraZeneca for $220M - MSN
Aug Momentum: What are analysts’ price targets for FibroGen Inc.Inflation Watch & Stepwise Trade Execution Plans - خودرو بانک
Will FibroGen Inc. see short term momentumQuarterly Portfolio Report & Precise Entry and Exit Recommendations - Newser
Will breakout in FibroGen Inc. lead to full recovery2025 Risk Factors & Intraday High Probability Alerts - Newser
Is FibroGen Inc. stock a value trapDip Buying & Low Risk Entry Point Tips - خودرو بانک
Is FibroGen Inc. stock entering bullish territoryEntry Point & AI Forecasted Entry/Exit Points - Newser
Is FibroGen Inc. stock poised for growthQuarterly Market Review & Trade Opportunity Analysis - Newser
Price momentum metrics for FibroGen Inc. explainedQuarterly Investment Review & Weekly Watchlist of Top Performers - Newser
Can machine learning forecast FibroGen Inc. recovery2025 Analyst Calls & Consistent Growth Equity Picks - Newser
FibroGen stock maintains Buy rating at H.C. Wainwright after China sale - Investing.com Nigeria
Volume spikes in FibroGen Inc. stock – what they mean2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Using R and stats models for FibroGen Inc. forecastingWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser
Is FibroGen Inc. stock forming a triangle patternJuly 2025 Setups & Verified Trade Idea Suggestions - khodrobank.com
What technical models suggest about FibroGen Inc.’s comebackEntry Point & Smart Investment Allocation Insights - Newser
What are analysts’ price targets for FibroGen Inc.July 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
Custom strategy builders for tracking FibroGen Inc.Portfolio Risk Summary & AI Powered Market Trend Analysis - Newser
How to use a screener to detect FibroGen Inc. breakoutsWeekly Profit Analysis & Breakout Confirmation Alerts - Newser
Fibrogen Inc (FGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):